Koa Shoji Holdings Co.,Ltd. (9273.T) JPX
Currency In JPY
- General
- Statistics
- Historical Data
- Profile
- Financials
Koa Shoji Holdings Co.,Ltd.
Address
13-15, Hiyoshi 7-chome
Yokohama, 223-0061
Japan
Phone
+81 45 624 8111
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
289
First IPO Date
June 21, 2018
Key Executives
| Name | Title | Pay | Year Born |
| Toshiyuki Shuto | President, Chief Executive Officer & Chairman of the Board of Directors | 0 | 1947 |
| Miyoko Komatsu | MD of Finance & Accounting and Director | 0 | 1964 |
| Teruyuki Tanaka | Director of Business Development & Corporate Planning & Director | 0 | 1950 |
| Toshihiro Hirono | MD & Director | 0 | 1949 |
| Toshinori Koyama | Executive MD of Sales & Director | 0 | 1948 |
| Ritsuko Ohtsuka | Executive Vice President, MD, Sustainability Officer & Director | 0 | 1978 |
| Yuki Toyoda | Executive Officer & GM of the General Affairs Department | 0 | N/A |
Description
Koa Shoji Holdings Co.,Ltd., established in 1991 and headquartered in Yokohama, Japan, operates through its subsidiaries, engaging in a diverse array of pharmaceutical activities. The company sources and distributes active pharmaceutical ingredients and their precursors throughout the Japanese market. Additionally, it is involved in the production and commercialization of a range of injectable medications, alongside over-the-counter drugs, with a particular emphasis on vitamin formulations. Koa Shoji Holdings also manufactures and distributes generic pharmaceuticals. Complementing these operations, the firm provides outsourced drug production services and offers specialized packaging solutions for medicinal products.
